Prakash Harikrishnan et al. JACEP 2015;1:

Slides:

Advertisements

Similar presentations

From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.

Advertisements

From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.

Tom F. Brouwer et al. JACEP 2016;2:89-96

Prakash Harikrishnan et al. JACEP 2015;1:

Prakash Harikrishnan et al. JACEP 2015;1:

Noriko Kikuchi et al. JACEP 2016;2:

Wouter M. van Everdingen et al. JACEP 2015;1:

Waddah Maskoun et al. JACEP 2016;2:

Pablo Ávila et al. JACEP 2015;1:

Daniel Frenkel et al. JACEP 2016;2:

Shadi Al Halabi et al. JACEP 2015;1:

Dean J. Kereiakes et al. JACC 2017;70:

Kenshi Hayashi et al. JACEP 2016;2:

Tom F. Brouwer et al. JACEP 2016;2:89-96

David S. Frankel et al. JACEP 2015;1:

Jose C. Pachon M. et al. JACEP 2015;1:

David F. Katz et al. JACEP 2016;j.jacep

Simon W. Rabkin et al. JACEP 2017;j.jacep

Pablo B. Nery et al. JACEP 2016;2:

Sébastien P.J. Krul et al. JACEP 2015;1:

Mintu P. Turakhia et al. JACEP 2016;2:

Simon W. Rabkin et al. JACEP 2017;j.jacep

Junjie Zhang et al. JACEP 2017;3:

Pugazhendhi Vijayaraman et al. JACEP 2015;1:

Jong Sung Park et al. JACEP 2016;2:

Simon W. Rabkin et al. JACEP 2017;3:

Peter F. Aziz et al. JACEP 2015;1:62-70

Mohit K. Turagam et al. JACEP 2017;3:

Flow chart of the study population according to thienopyridines used in the FAST-MI registry in patients with STEMI and NSTEMI. FAST-MI, French Registry.

Moussa Mansour et al. JACEP 2017;3:

Mintu P. Turakhia et al. JACEP 2016;2:

Leonard M. Rademakers et al. JACEP 2016;2:

Prakash Harikrishnan et al. JACEP 2015;1:

Rachel Bastiaenen et al. JACEP 2016;2:

National Trends in the Incidence, Management, and Outcomes of Heart Failure Complications in Patients Hospitalized for ST-Segment Elevation Myocardial.

Jacob S. Koruth et al. JACEP 2015;1:

Nat. Rev. Cardiol. doi: /nrcardio

S.M. Afzal Sohaib et al. JACEP 2015;1:

Prabhat Kumar et al. JACEP 2016;j.jacep

APD Restitution and Ventricular Arrhythmia Inducibility (A to D) Examples of dynamic APD restitution curves at remote (A and C) and peri-infarcted (B and.

Yoshitaka Kimura et al. JACEP 2016;2:

Emilce Trucco et al. JACEP 2018;j.jacep

Marwan Badri et al. JACEP 2015;1:

Junjie Zhang et al. JACEP 2017;3:

Kenshi Hayashi et al. JACEP 2016;2:

Adam B. Greenbaum et al. JACEP 2015;1:

David F. Katz et al. JACEP 2017;3:20-28

Moussa Mansour et al. JACEP 2016;j.jacep

Takumi Higuma et al. JCIN 2016;9:

Eran Leshem et al. JACEP 2017;j.jacep

Stuart A. Ostby et al. JACEP 2016;2:

Ayman A. Hussein et al. JACEP 2017;3:1-9

Simon W. Rabkin et al. JACEP 2017;3:

Emilce Trucco et al. JACEP 2018;j.jacep

K.R. Julian Chun et al. JACEP 2017;3:

Pugazhendhi Vijayaraman et al. JACEP 2015;1:

Björn Redfors et al. JACEP 2017;j.jacep

Miyako Igarashi et al. JACEP 2018;4:

Eric A. Osborn, and Farouc A. Jaffer JIMG 2013;6:

Any, acute and subacute stent thrombosis with bivalirudin versus unfractionated heparin (UFH) in predominantly ST segment elevation myocardial infarction.

Amar M. Salam, MBBS, MRCP, Hajar A. Albinali, MD, Abdurrazzak A

Major bleeding with bivalirudin versus unfractionated heparin (UFH) in predominantly ST segment elevation myocardial infarction (STEMI) studies; (A) glycoprotein.

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

Kaplan-Meier curves for the end point all-cause mortality in the total patient population stratified according to complete/incomplete revascularisation.

Jeffrey Senfield et al. JACEP 2017;3:

Use of evidence-based cardiac medications before, during and after hospitalisation for the index event in (A) overall ACS population and (B) patients with.

(Case 3) Acute, isolated posterior wall myocardial infarction.

Federico Migliore et al. JIMG 2013;6:32-41

Distribution of left atrial (LA) remodel.

Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.

Presentation transcript:

Prakash Harikrishnan et al. JACEP 2015;1:529-538 Trends in Incidence of CHB Complicating STEMI The percentage of complete heart block (CHB) was calculated as the number of patients with CHB divided by the number of patients with ST-segment elevation myocardial infarction (STEMI) per year × 100. (A) Trends in incidence of CHB in the overall cohort of patients with STEMI (ptrend <0.001). (B) Trends in incidence of CHB in patients with anterior STEMI (ptrend <0.001), inferior STEMI (ptrend <0.001), and other STEMI (ptrend <0.001). Prakash Harikrishnan et al. JACEP 2015;1:529-538 American College of Cardiology Foundation